Price
$8.84
Increased by +2.43%
Dollar volume (20D)
9.48 M
ADR%
6.00
Shares float
69.50 M
Shares short
12.52 M [18.01%]
Shares outstanding
87.01 M
Market cap
750.92 M
Beta
1.95
Price/earnings
N/A
20D range
8.31 9.91
50D range
7.15 9.91
200D range
5.15 16.73

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies.

The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial.

Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335.

Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 12, 25 -0.52
Increased by +79.28%
-0.81
Increased by +35.80%
Mar 26, 25 -1.11
Increased by +73.70%
-0.61
Decreased by -82.72%
Nov 7, 24 -0.78
Decreased by -116.67%
-0.56
Decreased by -39.29%
Aug 9, 24 -0.49
Decreased by -6.52%
-0.39
Decreased by -25.64%
May 14, 24 -2.51
Decreased by -617.14%
-0.69
Decreased by -263.77%
Mar 28, 24 -4.22
Decreased by -559.37%
-0.28
Decreased by -1.41 K%
Nov 9, 23 -0.36
Increased by +52.00%
-0.17
Decreased by -111.76%
Aug 9, 23 -0.46
Increased by +37.84%
-0.16
Decreased by -187.50%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 2.93 M
Increased by +184.35%
-41.64 M
Increased by +67.84%
Decreased by -1.42 K%
Increased by +88.69%
Dec 31, 24 2.74 M
Decreased by -28.44%
-80.25 M
Increased by +13.37%
Decreased by -2.93 K%
Decreased by -21.05%
Sep 30, 24 2.91 M
Decreased by -18.37%
-47.10 M
Decreased by -984.00%
Decreased by -1.62 K%
Decreased by -1.23 K%
Jun 30, 24 2.36 M
Decreased by -44.55%
-36.12 M
Decreased by -550.03%
Decreased by -1.53 K%
Decreased by -1.07 K%
Mar 31, 24 1.03 M
Decreased by -56.47%
-129.49 M
Decreased by -3.08 K%
Decreased by -12.58 K%
Decreased by -7.21 K%
Dec 31, 23 3.83 M
Increased by +N/A%
-92.63 M
Decreased by -1.00 K%
Decreased by -2.42 K%
Decreased by N/A%
Sep 30, 23 3.56 M
Increased by +N/A%
-4.34 M
Increased by +49.07%
Decreased by -121.88%
Decreased by N/A%
Jun 30, 23 4.26 M
Increased by +N/A%
-5.56 M
Increased by +37.72%
Decreased by -130.35%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY